Kintor PharmaceuticalKNTPF 20 Days Payable is 386.93 as of Dec. 2025, which is 72% below its 10-year median of 1,360.86. GuruFocus rates KNTPF with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 705 Biotechnology companies, Kintor Pharmaceutical ranks better than 81.28% on this metric.
Kintor Pharmaceutical Days Payable Historical Data
* Premium members only.
The historical data trend for Kintor Pharmaceutical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KNTPF vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Kintor Pharmaceutical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kintor Pharmaceutical Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kintor Pharmaceutical's Days Payable distribution charts can be found below:
* The bar in red indicates where Kintor Pharmaceutical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Kintor Pharmaceutical's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kintor Pharmaceutical (KNTPF) has a Days Payable of 386.93 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kintor Pharmaceutical and its competitors. This is 72% below median its historical median of 1,360.86. Over the past decade, Kintor Pharmaceutical's Days Payable has ranged from 531.03 to 9,684.85. According to the industry distribution chart, Kintor Pharmaceutical ranks #132 out of 705 companies in the Biotechnology industry, placing it in the top 18.7%.
Is Kintor Pharmaceutical's Days Payable too high?
Kintor Pharmaceutical's current Days Payable of 386.93 is 72% below median its 10-year median of 1,360.86. Over the past 10 years, this metric has ranged from a low of 531.03 to a high of 9,684.85. The Biotechnology industry median Days Payable is 113.36. Kintor Pharmaceutical's value of 386.93 is 241.3% above this industry median. Based on the distribution chart, Kintor Pharmaceutical ranks #132 out of 705 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Kintor Pharmaceutical has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Kintor Pharmaceutical's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kintor Pharmaceutical ranks #132 out of 705 companies for Days Payable. This places Kintor Pharmaceutical in the top 19% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.36. Kintor Pharmaceutical's value of 386.93 is 241.3% above this benchmark. Historically, Kintor Pharmaceutical's own Days Payable has ranged from 531.03 to 9,684.85 over the past decade. While the company's 10-year median is 1,360.86 vs. the industry median of 113.36, Kintor Pharmaceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.36, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kintor Pharmaceutical's current Days Payable of 386.93 is 241.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kintor Pharmaceutical and its competitors. For the Biotechnology industry, the median Days Payable is 113.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kintor Pharmaceutical's current Days Payable is 386.93, which is 72% below median its own 10-year median of 1,360.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kintor Pharmaceutical stock overvalued right now?
Kintor Pharmaceutical (KNTPF) has a current Days Payable of 386.93. The current Days Payable is 386.93, which is 72% below median its 10-year median of 1,360.86 and 241.3% above the Biotechnology industry median of 113.36. Kintor Pharmaceutical's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Kintor Pharmaceutical (KNTPF), the current Days Payable is 386.93 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China, focusing on developing therapeutic drugs for unmet medical needs. Its pipelines cover indications of dermatology, such as AGA and acne vulgaris, and indications of tumors, catering to the unmet medical needs of patients and cosmetics consumers globally. The Group's cosmetic product types include anti-hair loss, acne treatment, and skin whitening products. Kintor's pipeline consists of various drug candidates such as KX-826, AR-PROTAC Compound (GT20029), GT1708F (Hedgehog/SMO Inhibitor), GT0486, and ALK-1 Antibody (GT90001). It has only one reportable operating segment, which is engaged in the research and development of medicine products and extends to functional cosmetics and raw materials.
20GF Score
Get the complete analysis for KNTPF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KNTPF has been successfully added to your 
